received a NHMRC Senior Principal Research Fellowship (grant ID: 1154434), a NHMRC Leadership grant (ID: 2025694), and an ARC Discovery Project grant (DP210101504)
Is the enzyme ACMSD a novel therapeutic target in Parkinsons disease
Cerebral blood supply At rest, the brain receives approximately 15% of cardiac output (9)
Older research reviews did not provide modern, well-quantified long-term safety outcomes [1]
Some support lean mass and performance
Multiple mechanisms drive pathological ROS accumulation in diabetic cardiomyocytes, such as inhibition of mitochondrial oxidative phosphorylation elevating O 2 production, activation of NOX by angiotensin II (Ang II) and TNF-, and AGEs-RAGE binding-induced NF-B activation that triggers inflammation and further ROS generation